Simpson-Golabi-Behmel syndrome synonyms

Simpson-Golabi-Behmel syndrome (SGBS) is a rare X-linked overgrowth condition that is most commonly referred to by its eponymous name, though it has been historically categorized under several terms including Golabi-Rosen syndrome and Bulldog syndrome. Because the condition was first described by different researchers in the mid-1970s, older medical records may reflect these historical names, but Simpson-Golabi-Behmel syndrome is the current standard nomenclature used by geneticists and clinical databases worldwide.

Why does Simpson-Golabi-Behmel syndrome have multiple names?

The nomenclature of Simpson-Golabi-Behmel syndrome reflects the history of its discovery. In the 1970s and 1980s, independent research groups identified patients with similar overgrowth patterns and distinct facial features, initially describing them as separate entities. Over time, clinical and genetic studies confirmed that these reports were describing the same underlying condition caused by mutations in the GPC3 gene. As our understanding of the genetic architecture of Simpson-Golabi-Behmel syndrome improved, the medical community consolidated these various descriptions into a single, unified name to ensure consistency in clinical diagnosis and research.

What are the historical and alternative names for this condition?

When reviewing older medical literature or international health records, you may encounter several synonyms for Simpson-Golabi-Behmel syndrome. Understanding these terms can be crucial for patients and families navigating long-term medical records or international research papers. Common synonyms and historical designations include:

• Golabi-Rosen syndrome: An early designation based on initial case reports.


• Bulldog syndrome: A descriptive, historical term referencing the distinct facial features sometimes observed in patients.


• G syndrome: A rare, abbreviated historical reference.


• X-linked gigantism syndrome: A descriptive name highlighting the overgrowth pattern associated with the condition.


• Simpson dysmorphia syndrome: Named after one of the original researchers who helped characterize the clinical features.

How is Simpson-Golabi-Behmel syndrome classified in medical databases?

To standardize care, medical professionals rely on specific international codes and databases. Simpson-Golabi-Behmel syndrome is officially recognized in the following systems:

1. OMIM (Online Mendelian Inheritance in Man): Listed under entry #312870.


2. Orphanet: Identified by the unique identifier ORPHA:3240.


3. ICD-10/11: While the condition itself is rare, it is often coded under broader categories related to genetic overgrowth syndromes (e.g., Q87.3 in ICD-10 for congenital hypertrophy syndromes).

Currently, Simpson-Golabi-Behmel syndrome is the preferred term in all peer-reviewed clinical literature and by major patient advocacy organizations. Using the official name ensures that your healthcare team can access the most up-to-date diagnostic criteria and management guidelines.

Why is accurate nomenclature important for our community?

At DiseaseMaps.org, we have observed that 26 people with Simpson-Golabi-Behmel syndrome have joined our community to share their experiences. Having a unified name allows these families to connect more effectively, share resources, and participate in clinical research. When researchers and clinicians use a single, consistent name, it accelerates the pace of discovery and improves the quality of care for every individual living with this condition.

Next steps

• Consult a board-certified clinical geneticist to confirm your diagnosis using the standard name Simpson-Golabi-Behmel syndrome.


• Review your medical records; if you see older terms like "Bulldog syndrome," ask your physician to update your records to the current nomenclature for clarity.


• Connect with the DiseaseMaps.org community to share your journey and learn from the experiences of others living with this rare condition.


• Reach out to organizations like the NIH GARD to access the latest clinical trial information and patient support resources.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet: Simpson-Golabi-Behmel syndrome (ORPHA:3240).


• OMIM: Simpson-Golabi-Behmel Syndrome, Type 1 (Entry #312870).


• NIH GARD: Simpson-Golabi-Behmel syndrome overview and patient resources.